Literature DB >> 24021278

MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface.

Hiroki Tsukamoto1, Hideyuki Ihara, Ritsu Ito, Ippo Ukai, Naoto Suzuki, Masao Kimoto, Yoshihisa Tomioka, Yoshitaka Ikeda.   

Abstract

MD-2 is essential for lipopolysaccharide (LPS) recognition of Toll-like receptor 4 (TLR4) but not for cell surface expression. The TLR4/MD-2 complex is formed intracellularly through co-expression. Extracellular complex formation remains a matter for debate because of the aggregative nature of secreted MD-2 in the absence of TLR4 co-expression. We demonstrated extracellular complex formation using three independent monoclonal antibodies (mAbs), all of which are specific for complexed TLR4 but unreactive with free TLR4 and MD-2. These mAbs bound to TLR4-expressing Ba/F3 cells only when co-cultured with MD-2-secreting Chinese hamster ovary cells or incubated with conditioned medium from these cells. All three mAbs bound the extracellularly formed complex indistinguishably from the intracellularly formed complex in titration studies. In addition, we demonstrated that two mAbs lost their affinity for TLR4/MD-2 on LPS stimulation, suggesting that these mAbs bound to conformation-sensitive epitopes. This was also found when the extracellularly formed complex was stimulated with LPS. Additionally, we showed that cell surface TLR4 and extrinsically secreted MD-2 are capable of forming the functional complex extracellularly, indicating an additional or alternative pathway for the complex formation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bio-; C-terminally FLAG-tagged MD-2; CM; FCS; LBP; LBP-N; LPS; LPS-binding protein; Lipopolysaccharide; MD-2; MD-2F; Monoclonal antibody; PE; TLR; Toll-like receptor; Toll-like receptor 4; biotinylated; conditioned medium; fetal calf serum; lipopolysaccharide; mAb; monoclonal antibody; phycoerythrin; sCD14; sMD-2; soluble MD-2; soluble form of CD14; streptavidin; stv; truncated N-terminal form of LBP

Mesh:

Substances:

Year:  2013        PMID: 24021278     DOI: 10.1016/j.bbrc.2013.09.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.

Authors:  Hiroki Tsukamoto; Kanae Kubota; Ayumi Shichiku; Masamitsu Maekawa; Nariyasu Mano; Hideo Yagita; Shoichiro Ohta; Yoshihisa Tomioka
Journal:  Immunology       Date:  2019-10       Impact factor: 7.397

2.  Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.

Authors:  Hiroki Tsukamoto; Shino Takeuchi; Kanae Kubota; Yohei Kobayashi; Sao Kozakai; Ippo Ukai; Ayumi Shichiku; Misaki Okubo; Muneo Numasaki; Yoshitomi Kanemitsu; Yotaro Matsumoto; Tomonori Nochi; Kouichi Watanabe; Hisashi Aso; Yoshihisa Tomioka
Journal:  J Biol Chem       Date:  2018-05-14       Impact factor: 5.157

Review 3.  TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.

Authors:  Anna Ciesielska; Marta Matyjek; Katarzyna Kwiatkowska
Journal:  Cell Mol Life Sci       Date:  2020-10-15       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.